The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Lamotrigine for central poststroke pain: A randomized controlled trial
Abstract
OBJECTIVE: Central poststroke pain (CPSP) is usually difficult to treat. Amitriptyline, the only oral preparation shown to be effective in a randomized controlled trial, is often associated with a range of side effects related to the many mechanisms of actions of tricyclic antidepressants. We investigated the effect of lamotrigine, a drug that reduces neuronal hyperexcitability, on poststroke pain. METHODS: Thirty consecutive patients with CPSP (median age 59 years, range 37 to 77; median pain duration 2.0 years, range 0.3 to 12) from two centers participated in a randomized, double-blind, placebo-controlled cross-over study. The study consisted of two 8-week treatment periods separated by 2 weeks of wash-out. The primary endpoint was the median value of the mean daily pain score during the last week of treatment while treated with 200 mg/d lamotrigine. Secondary endpoints were median pain scores while on lamotrigine 25 mg/d, 50 mg/d, and 100 mg/d; a global pain score; assessment of evoked pain; areas of spontaneous pain; and allodynia/dysesthesia. RESULTS: Lamotrigine 200 mg/d reduced the median pain score to 5, compared to 7 during placebo (p = 0.01) in the intent-to-treat population of 27 patients. No significant effect was obtained at lower doses. Twelve patients (44%) responded to the treatment. There was a uniform tendency to reduction of all secondary outcome measures, but lamotrigine only had significant effects on some of the secondary outcome measures. Lamotrigine was well tolerated with few and transient side effects. Two mild rashes occurred during lamotrigine treatment, one causing withdrawal from study. CONCLUSIONS: Oral lamotrigine 200 mg daily is a well tolerated and moderately effective treatment for central poststroke pain. Lamotrigine may be an alternative to tricyclic antidepressants in the treatment of CPSP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sensory disturbances from cerebral lesions
HEAD, H., & HOLMES, G. (1911) · Brain · doi:10.1093/brain/34.2-3.102 · Cited by 1,852
Sindrup, S. H., & Jensen, T. S. (1999) · Pain · doi:10.1016/s0304-3959(99)00154-2 · Cited by 1,144
Self-citationIncidence of central post-stroke pain
Andersen, G., Vestergaard, K., Ingeman-Nielsen, M., & Jensen, T. S. (1995) · Pain · doi:10.1016/0304-3959(94)00144-4 · Cited by 465
Self-citationZakrzewska, J. M., Chaudhry, Z., Nurmikko, T. J., Patton, D. W., & Mullens, L. E. (1997) · Pain · doi:10.1016/s0304-3959(97)00104-8 · Cited by 402
Central post-stroke pain — a controlled trial of amitriptyline and carbamazepine
Leijon, G., & Boivie, J. (1989) · Pain · doi:10.1016/0304-3959(89)90108-5 · Cited by 392
Central post-stroke pain — a study of the mechanisms through analyses of the sensory abnormalities
Boivie, J., Leijon, G., & Johansson, I. (1989) · Pain · doi:10.1016/0304-3959(89)90128-0 · Cited by 367
Intravenous lidocaine in central pain: A double-blind, placebo-controlled, psychophysical study
Attal, N., Gaudé, V., Brasseur, L., Dupuy, M., Guirimand, F., Parker, F., & Bouhassira, D. (2000) · Neurology · doi:10.1212/wnl.54.3.564 · Cited by 293
Central pain: clinical and physiological characteristics.
Bowsher, D. (1996) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.61.1.62 · Cited by 253
Safety Review of Adult Clinical Trial Experience with Lamotrigine
Messenheimer, J., Mullens, E. L., Giorgi, L., & Young, F. (1998) · Drug Safety · doi:10.2165/00002018-199818040-00004 · Cited by 252
Lees, G., & Leach, M. J. (1993) · Brain Research · doi:10.1016/0006-8993(93)91660-k · Cited by 247
Cited by
Winstein, C. J., Stein, J., Arena, R., Bates, B., Cherney, L. R., Cramer, S. C., Deruyter, F., Eng, J. J., Fisher, B., Harvey, R. L., et al. (2016) · Stroke · doi:10.1161/str.0000000000000098 · Cited by 3,293
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
Attal, N., Cruccu, G., Baron, R., Haanpää, M., Hansson, P., Jensen, T. S., & Nurmikko, T. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.02999.x · Cited by 1,873
Self-citationAlgorithm for neuropathic pain treatment: An evidence based proposal
Finnerup, N. B., Otto, M., McQuay, H. J., Jensen, T. S., & Sindrup, S. H. (2005) · Pain · doi:10.1016/j.pain.2005.08.013 · Cited by 1,330
Self-citationDevelopment and validation of the Neuropathic Pain Symptom Inventory
Bouhassira, D., Attal, N., Fermanian, J., Alchaar, H., Gautron, M., Masquelier, E., Rostaing, S., Lanteri-Minet, M., Collin, E., Grisart, J., et al. (2004) · Pain · doi:10.1016/j.pain.2003.12.024 · Cited by 1,329
Advances in Neuropathic Pain: Diagnosis, Mechanisms, and Treatment Recommendations
Dworkin, R. H., Backonja, M., Rowbotham, M. C., Allen, R. R., Argoff, C. R., Bennett, G. J., Bushnell, M. C., Farrar, J. T., Galer, B. S., Haythornthwaite, J. A., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.11.1524 · Cited by 1,216
Metadata
- Authors
- Vestergaard, K., Andersen, G., Gottrup, H., Kristensen, B. T., & Jensen, T. S.
- Venue
- Neurology
- Published
- 2001-01-23
- Volume
- 56
- Issue
- 2
- Pages
- 184-190
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2003555425
- Cited by
- 324
- References
- 23
- FWCI
- 23.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lamotrigine for central poststroke pain: A randomized controlled trial. https://app.cochat.ai/papers/10.1212/wnl.56.2.184
- The paper
- Vestergaard, K., Andersen, G., Gottrup, H., Kristensen, B. T., & Jensen, T. S. (2001). Lamotrigine for central poststroke pain: A randomized controlled trial. Neurology. https://doi.org/10.1212/wnl.56.2.184
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.